Capital International Investors
FLXN

Capital International Investors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Capital International Investors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-650,000
Closed -$12.2M – 398
2018
Q3 		$12.2M Buy
+650,000
New +$14.9M 0.01% 344

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors's FLXN Position: Q4 2018 in Review

Capital International Investors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2018, closing a stake of 650,000 shares — an estimated $12.2M sold.

Capital International Investors first reported a position in FLXN in Q3 2018 and held it in 1 quarter. The position peaked at $12.2M in Q3 2018. 125 funds tracked by Wall St. Rank hold FLXN as of Q4 2018.

  • Capital International Investors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Capital International Investors sold 650,000 Flexion Therapeutics, Inc. shares in Q4 2018, an estimated $12.2M.
  • Capital International Investors first reported a position in Flexion Therapeutics, Inc. in Q3 2018 and held it in 1 quarter.
  • Capital International Investors's Flexion Therapeutics, Inc. position peaked at $12.2M in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2018.

Based on Capital International Investors's 13F filing for Q4 2018, filed 14 Feb 2019.